Stocks · Health care · Pharmaceutical Preparations

Protagonist Therapeutics, Inc

PTGX Clue Score48
United States Fiscal year ends December CIK 0001377121 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Harold E Selick
12 Mar 2020
Director
Buy
12,000
$6.70
$80.40K
Dinesh V Ph D Patel
3 Dec 2019
President and CEO
Buy
20,000
$5.65
$113.00K
Dinesh V Ph D Patel
3 Dec 2019
President and CEO
Buy
10,000
$5.55
$55.50K
Donald A. Kalkofen
3 Dec 2019
Chief Financial Officer
Buy
562
$5.09
$2.86K
Donald A. Kalkofen
3 Dec 2019
Chief Financial Officer
Buy
613
$5.10
$3.13K
Suneel Gupta
3 Dec 2019
EVP Clinical Operations
Buy
30,000
$5.13
$153.90K
Bryan Giraudo
3 Dec 2019
Director
Buy indirect
8,000
$5.70
$45.62K
Bryan Giraudo
16 May 2017
Director
Buy
10,000
$6.46
$64.57K

What was left out

Form 4 filings counted 247
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 70
Sales at will 49
Transactions with no price 0
Shares from compensation/vesting 2,924,555
Sales filed before the plan box existed 25
History held since 16 Aug 2016